• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    8/2/23 1:55:33 PM ET
    $RDHL
    $RDWR
    $SILV
    $SNES
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate
    Real Estate
    Get the next $RDHL alert in real time by email

     

    During Wednesday's trading, 103 companies set new 52-week lows.

    Interesting Facts About Today's 52-Week Lows:

    • Estee Lauder Cos (NYSE:EL) was the biggest company in terms of market cap to set a new 52-week low.
    • Esports Entertainment (NASDAQ:GMBL) was the smallest company in terms of market cap to set a new 52-week low.
    • ExlService Holdings (NASDAQ:EXLS)'s stock moved significantly downwards, trading down 80.66% to reach a new 52-week low.
    • IDT (NYSE:IDT) saw the biggest bounce back on, as shares traded up 0.04% to rebound after it hit its new 52-week low.

    The following stocks created new 52-week lows on Wednesday:

    • Estee Lauder Cos (NYSE:EL) stock drifted down 1.97% on Wednesday morning to hit a new 52-week low of $170.90.
    • Moderna (NASDAQ:MRNA) shares hit a yearly low of $110.84. The stock was down 2.27% on the session.
    • TELUS (NYSE:TU) shares set a new yearly low of $17.32 this morning. The stock was down 2.17% on the session.
    • Enphase Energy (NASDAQ:ENPH) stock drifted down 5.9% on Wednesday morning to hit a new 52-week low of $140.28.
    • ZoomInfo Technologies (NASDAQ:ZI) shares reached a new 52-week low of $18.31 on Wednesday morning, moving down 0.59%.
    • Agree Realty (NYSE:ADC) stock dropped to a yearly low on Wednesday of $62.79. Shares traded down 2.8%.
    • ExlService Holdings (NASDAQ:EXLS) stock dropped to a yearly low on Wednesday of $27.22. Shares traded down 80.66%.
    • PNM Resources (NYSE:PNM) stock set a new 52-week low of $44.30 on Wednesday, moving down 0.39%.
    • Insperity (NYSE:NSP) shares hit a yearly low of $94.00. The stock was down 3.56% on the session.
    • Spire (NYSE:SR) stock hit $59.49 on Wednesday morning, setting a new 52-week low for a change of down 3.4%.
    • NovoCure (NASDAQ:NVCR) stock drifted down 6.98% on Wednesday morning to hit a new 52-week low of $30.21.
    • Cytokinetics (NASDAQ:CYTK) stock achieved a new 52-week low on Wednesday morning, hitting $31.46 and moving down 1.54%.
    • Clearway Energy (NYSE:CWEN) shares set a new 52-week low of $25.17. The stock traded down 2.48%.
    • National Storage (NYSE:NSA) shares fell to $32.80 on Wednesday, setting a new 52-week low with a shift of down 0.8%.
    • Apellis Pharmaceuticals (NASDAQ:APLS) stock set a new 52-week low of $22.73 on Wednesday, moving down 4.91%.
    • Sensient Technologies (NYSE:SXT) stock broke to a new 52-week low of $62.64 on Wednesday. Shares of the company traded down 1.48%.
    • TELUS Intl (NYSE:TIXT) shares fell to $8.74 on Wednesday, setting a new 52-week low with a shift of down 3.41%.
    • Driven Brands Hldgs (NASDAQ:DRVN) stock hit a new 52-week low of $13.15. The stock was down 48.68% on the session.
    • Beam Therapeutics (NASDAQ:BEAM) shares set a new yearly low of $27.46 this morning. The stock was down 1.86% on the session.
    • Perficient (NASDAQ:PRFT) stock dropped to a yearly low on Wednesday of $58.94. Shares traded down 2.74%.
    • Impinj (NASDAQ:PI) stock drifted down 4.11% on Wednesday morning to hit a new 52-week low of $62.44.
    • Pacira BioSciences (NASDAQ:PCRX) shares fell to $34.08 on Wednesday, setting a new 52-week low with a shift of up 0.64%.
    • SunPower (NASDAQ:SPWR) stock broke to a new 52-week low of $8.94 on Wednesday. Shares of the company traded down 8.99%.
    • Maravai LifeSciences (NASDAQ:MRVI) shares fell to $10.78 on Wednesday, setting a new 52-week low with a shift of up 4.94%.
    • Duckhorn Portfolio (NYSE:NAPA) shares were down 0.12% for the day, having made a 52-week low of $12.35.
    • Nu Skin Enterprises (NYSE:NUS) shares hit a yearly low of $27.50. The stock was down 6.29% on the session.
    • BioCryst Pharma (NASDAQ:BCRX) stock hit a yearly low of $6.78. The stock was down 0.22% for the day.
    • Horace Mann Educators (NYSE:HMN) stock broke to a new 52-week low of $28.15 on Wednesday. Shares of the company traded down 5.68%.
    • Monro (NASDAQ:MNRO) stock broke to a new 52-week low of $34.94 on Wednesday. Shares of the company traded down 2.34%.
    • Hain Celestial Group (NASDAQ:HAIN) stock broke to a new 52-week low of $11.50 on Wednesday. Shares of the company traded down 2.59%.
    • Infinera (NASDAQ:INFN) stock hit a yearly low of $4.22. The stock was down 2.19% for the day.
    • Suburban Propane Partners (NYSE:SPH) stock broke to a new 52-week low of $14.42 on Wednesday. Shares of the company traded down 0.96%.
    • IntL Money Express (NASDAQ:IMXI) stock hit a yearly low of $19.31. The stock was down 16.84% for the day.
    • Radware (NASDAQ:RDWR) shares set a new yearly low of $14.96 this morning. The stock was down 15.39% on the session.
    • Nevro (NYSE:NVRO) shares set a new yearly low of $18.55 this morning. The stock was down 23.88% on the session.
    • SilverCrest Metals (AMEX:SILV) stock dropped to a yearly low on Wednesday of $4.16. Shares traded down 6.15%.
    • IDT (NYSE:IDT) shares fell to $22.76 on Wednesday, setting a new 52-week low with a shift of up 0.04%.
    • Anterix (NASDAQ:ATEX) stock hit a yearly low of $27.20. The stock was up 2.05% for the day.
    • ModivCare (NASDAQ:MODV) shares set a new 52-week low of $35.68. The stock traded down 2.0%.
    • Beneficient (NASDAQ:BENF) shares set a new yearly low of $1.80 this morning. The stock was down 6.5% on the session.
    • Artesian Resources (NASDAQ:ARTNA) shares fell to $45.01 on Wednesday, setting a new 52-week low with a shift of up 0.53%.
    • Fate Therapeutics (NASDAQ:FATE) stock achieved a new 52-week low on Wednesday morning, hitting $3.73 and moving down 4.79%.
    • 2seventy bio (NASDAQ:TSVT) shares moved down 3.03% on Wednesday to hit a new 52-week low of $6.63, drifting down 3.03%.
    • PSQ Holdings (NYSE:PSQH) shares hit a yearly low of $11.57. The stock was down 6.55% on the session.
    • Cambium Networks (NASDAQ:CMBM) shares were down 37.64% for the day, having made a 52-week low of $8.84.
    • BRC (NYSE:BRCC) stock hit a new 52-week low of $4.21. The stock was down 4.39% on the session.
    • TPI Composites (NASDAQ:TPIC) shares moved down 0.78% on Wednesday to hit a new 52-week low of $5.53, drifting down 0.78%.
    • Gold Royalty (AMEX:GROY) stock hit $1.65 on Wednesday morning, setting a new 52-week low for a change of down 4.6%.
    • Nuveen Virginia Quality (NYSE:NPV) stock drifted down 0.92% on Wednesday morning to hit a new 52-week low of $10.60.
    • Orchestra BioMed Hldgs (NASDAQ:OBIO) shares set a new 52-week low of $5.19. The stock traded down 4.0%.
    • Prelude Therapeutics (NASDAQ:PRLD) shares were down 2.71% for the day, having made a 52-week low of $3.56.
    • NGM Biopharmaceuticals (NASDAQ:NGM) shares moved down 1.98% on Wednesday to hit a new 52-week low of $2.16, drifting down 1.98%.
    • Inogen (NASDAQ:INGN) shares set a new 52-week low of $7.54. The stock traded down 3.55%.
    • Akoustis Technologies (NASDAQ:AKTS) shares moved down 2.56% on Wednesday to hit a new 52-week low of $2.26, drifting down 2.56%.
    • Complete Solaria (NASDAQ:CSLR) shares hit a yearly low of $3.14. The stock was down 5.0% on the session.
    • Electrovaya (NASDAQ:ELVA) stock set a new 52-week low of $4.05 on Wednesday, moving up 4.1%.
    • Zevia (NYSE:ZVIA) stock dropped to a yearly low on Wednesday of $2.65. Shares traded down 2.36%.
    • Platinum Gr Metals (AMEX:PLG) shares set a new yearly low of $1.27 this morning. The stock was down 4.51% on the session.
    • Loop Media (AMEX:LPTV) stock hit a yearly low of $2.13. The stock was down 3.59% for the day.
    • G1 Therapeutics (NASDAQ:GTHX) shares set a new 52-week low of $2.11. The stock traded up 0.68%.
    • PaySign (NASDAQ:PAYS) shares fell to $1.82 on Wednesday, setting a new 52-week low with a shift of down 3.19%.
    • Byrna Technologies (NASDAQ:BYRN) shares were down 3.14% for the day, having made a 52-week low of $3.30.
    • TD Hldgs (NASDAQ:GLG) shares hit a yearly low of $0.47. The stock was down 2.69% on the session.
    • Ohmyhome (NASDAQ:OMH) shares were down 0.94% for the day, having made a 52-week low of $2.72.
    • Zapp Electric Vehicles (NASDAQ:ZAPP) shares made a new 52-week low of $1.40 on Wednesday. The stock was down 4.7% for the day.
    • AquaBounty Techs (NASDAQ:AQB) stock hit $0.31 on Wednesday morning, setting a new 52-week low for a change of down 9.97%.
    • Phoenix New Media (NYSE:FENG) stock achieved a new 52-week low on Wednesday morning, hitting $1.61 and moving up 1.2%.
    • Cosmos Health (NASDAQ:COSM) stock achieved a new 52-week low on Wednesday morning, hitting $1.35 and moving down 4.08%.
    • Polished.com (AMEX:POL) stock hit a new 52-week low of $0.17. The stock was down 13.61% on the session.
    • ShiftPixy (NASDAQ:PIXY) stock hit a new 52-week low of $1.01. The stock was down 7.21% on the session.
    • Treasure Global (NASDAQ:TGL) stock hit a new 52-week low of $0.65. The stock was down 6.3% on the session.
    • Tonix Pharmaceuticals (NASDAQ:TNXP) shares moved down 2.43% on Wednesday to hit a new 52-week low of $0.99, drifting down 2.43%.
    • Biophytis (NASDAQ:BPTS) shares were down 1.16% for the day, having made a 52-week low of $1.67.
    • Taoping (NASDAQ:TAOP) stock drifted down 13.12% on Wednesday morning to hit a new 52-week low of $4.11.
    • Yoshiharu Global (NASDAQ:YOSH) shares were down 4.96% for the day, having made a 52-week low of $0.51.
    • Universe Pharmaceuticals (NASDAQ:UPC) stock hit a new 52-week low of $1.68. The stock was down 8.68% on the session.
    • Redhill Biopharma (NASDAQ:RDHL) stock broke to a new 52-week low of $1.15 on Wednesday. Shares of the company traded down 7.2%.
    • Biolase (NASDAQ:BIOL) stock dropped to a yearly low on Wednesday of $5.11. Shares traded down 8.89%.
    • Synaptogenix (NASDAQ:SNPX) shares made a new 52-week low of $0.67 on Wednesday. The stock was down 8.51% for the day.
    • Phio Pharma (NASDAQ:PHIO) shares fell to $2.53 on Wednesday, setting a new 52-week low with a shift of down 2.99%.
    • NanoVibronix (NASDAQ:NAOV) shares moved down 5.37% on Wednesday to hit a new 52-week low of $2.82, drifting down 5.37%.
    • Digital Brands Group (NASDAQ:DBGI) shares set a new yearly low of $0.55 this morning. The stock was up 1.26% on the session.
    • Aptevo Therapeutics (NASDAQ:APVO) stock hit a yearly low of $0.58. The stock was down 39.89% for the day.
    • Intelligent Bio Solutions (NASDAQ:INBS) shares set a new 52-week low of $1.71. The stock traded down 1.21%.
    • Adamis Pharmaceuticals (NASDAQ:ADMP) shares set a new 52-week low of $1.28. The stock traded down 63.91%.
    • Ault Alliance (AMEX:AULT) shares set a new yearly low of $2.61 this morning. The stock was down 8.36% on the session.
    • Oblong (NASDAQ:OBLG) stock achieved a new 52-week low on Wednesday morning, hitting $1.22 and moving down 1.6%.
    • SenesTech (NASDAQ:SNES) shares were down 1.1% for the day, having made a 52-week low of $0.88.
    • NeuBase Therapeutics (NASDAQ:NBSE) stock achieved a new 52-week low on Wednesday morning, hitting $1.20 and moving down 1.55%.
    • Akanda (NASDAQ:AKAN) shares fell to $0.58 on Wednesday, setting a new 52-week low with a shift of down 3.78%.
    • Allarity Therapeutics (NASDAQ:ALLR) shares reached a new 52-week low of $2.24 on Wednesday morning, moving down 8.03%.
    • Esports Entertainment (NASDAQ:GMBL) stock dropped to a yearly low on Wednesday of $0.33. Shares traded down 13.88%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $RDHL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RDHL
    $RDWR
    $SILV
    $SNES

    CompanyDatePrice TargetRatingAnalyst
    Driven Brands Holdings Inc.
    $DRVN
    2/26/2026$12.00Overweight → Neutral
    Piper Sandler
    Zevia PBC
    $ZVIA
    2/26/2026$6.00 → $5.00Outperform
    Telsey Advisory Group
    Enphase Energy Inc.
    $ENPH
    2/25/2026$57.00Hold → Buy
    Jefferies
    Beam Therapeutics Inc.
    $BEAM
    2/20/2026$74.00Buy
    Canaccord Genuity
    BioCryst Pharmaceuticals Inc.
    $BCRX
    2/18/2026$17.00Outperform
    Evercore ISI
    Monro Inc.
    $MNRO
    2/11/2026$40.00Perform → Outperform
    Oppenheimer
    Estee Lauder Companies Inc.
    $EL
    2/10/2026$106.00Buy → Hold
    HSBC Securities
    Impinj Inc.
    $PI
    2/6/2026$112.00Outperform → In-line
    Evercore ISI
    More analyst ratings

    $RDHL
    $RDWR
    $SILV
    $SNES
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fetter Victor bought $149,540 worth of shares (3,500 units at $42.73), increasing direct ownership by 19% to 22,292 units (SEC Form 4)

    4 - HORACE MANN EDUCATORS CORP /DE/ (0000850141) (Issuer)

    2/27/26 2:17:53 PM ET
    $HMN
    Property-Casualty Insurers
    Finance

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $56,667 worth of shares (31,346 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/13/26 5:20:17 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $RDHL
    $RDWR
    $SILV
    $SNES
    SEC Filings

    View All

    SEC Form 10-K filed by Inogen Inc

    10-K - Inogen Inc (0001294133) (Filer)

    2/27/26 4:12:23 PM ET
    $INGN
    Industrial Specialties
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Orchestra BioMed Holdings Inc.

    SCHEDULE 13G/A - Orchestra BioMed Holdings, Inc. (0001814114) (Subject)

    2/27/26 4:07:23 PM ET
    $OBIO
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Akanda Corp.

    6-K - AKANDA CORP. (0001888014) (Filer)

    2/27/26 3:57:00 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    $RDHL
    $RDWR
    $SILV
    $SNES
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    FDA Approval for ZIMHI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug ZIMHI (ORIG-1) with active ingredient NALOXONE HYDROCHLORIDE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 212854, Application Classification: Type 5 - New Formulation or New Manufacturer

    10/18/21 11:55:40 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SYMJEPI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug SYMJEPI (SUPPL-12) with active ingredient EPINEPHRINE has changed to 'Approval' on 06/29/2021. Application Category: NDA, Application Number: 207534, Application Classification: Labeling

    6/30/21 5:11:48 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $RDHL
    $RDWR
    $SILV
    $SNES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    First Towers & Fiber Corp. Owns the Largest Dark Fiber Network in Central Mexico

    Toronto, Ontario--(Newsfile Corp. - February 27, 2026) - Akanda Corp. (NASDAQ:AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, announced today plans to further expand the leasing of its approximately 700-kilometre dark fiber optic network located in Central Mexico. The network represents the largest dark fiber infrastructure in the region, serving several of Mexico's most active industrial corridors and fastest-growing state economies.The network was constructed following the execution of a 20-year long-term dark fiber lease agreement with Telefónica, the Spanish multinationa

    2/27/26 8:30:00 AM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results

    — Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years — — Conference call today at 4:30 p.m. ET — BRISBANE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today reported financial results for the fourth quarter and full-year of 2025. "2025 was a year of disciplined execution for Pacira. With the launch of our 5x30 strategy, we reignited momentum across the business and delivered strong, measurable progress. Our products benefitted more than 2.5 million patients

    2/26/26 4:01:00 PM ET
    $PCRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TELUS is Canada's most awarded network ever by Opensignal

    Sweeping Opensignal's February 2026 report with ten top honours, TELUS solidifies its position as the Canadian carrier to beat for 5G coverage, gaming and overall reliability Delivering the fastest download speeds and unbeaten coverage, quality and reliability, TELUS offers Canadians an exceptional 5G experience from coast to coastTORONTO, Feb. 26, 2026 /CNW/ - Today, TELUS announced its industry-leading results from Opensignal's February, 2026 Canada Mobile Network Experience Report, receiving top honours in ten categories, including winning outright for 5G Gaming Experience and Time on 5G, with unbeaten coverage and reliability across Canada. These results make TELUS Canada's Most Awarded

    2/26/26 10:16:00 AM ET
    $TU
    Telecommunications Equipment
    Telecommunications

    $RDHL
    $RDWR
    $SILV
    $SNES
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fetter Victor bought $149,540 worth of shares (3,500 units at $42.73), increasing direct ownership by 19% to 22,292 units (SEC Form 4)

    4 - HORACE MANN EDUCATORS CORP /DE/ (0000850141) (Issuer)

    2/27/26 2:17:53 PM ET
    $HMN
    Property-Casualty Insurers
    Finance

    President Ciaramella Giuseppe exercised 35,000 shares at a strike of $17.00 and sold $1,120,042 worth of shares (35,000 units at $32.00) (SEC Form 4)

    4 - Beam Therapeutics Inc. (0001745999) (Issuer)

    2/26/26 4:05:04 PM ET
    $BEAM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Castro Joseph

    3 - NUVEEN VIRGINIA QUALITY MUNICIPAL INCOME FUND (0000897421) (Issuer)

    2/26/26 1:21:35 PM ET
    $NPV
    Investment Managers
    Finance

    $RDHL
    $RDWR
    $SILV
    $SNES
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Driven Brands downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Driven Brands from Overweight to Neutral and set a new price target of $12.00

    2/26/26 8:33:49 AM ET
    $DRVN
    Automotive Aftermarket
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on Zevia PBC with a new price target

    Telsey Advisory Group reiterated coverage of Zevia PBC with a rating of Outperform and set a new price target of $5.00 from $6.00 previously

    2/26/26 6:51:04 AM ET
    $ZVIA
    Beverages (Production/Distribution)
    Consumer Staples

    Enphase Energy upgraded by Jefferies with a new price target

    Jefferies upgraded Enphase Energy from Hold to Buy and set a new price target of $57.00

    2/25/26 7:19:45 AM ET
    $ENPH
    Semiconductors
    Technology

    $RDHL
    $RDWR
    $SILV
    $SNES
    Leadership Updates

    Live Leadership Updates

    View All

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board

    WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("Tectonic"), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced it has appointed François Nader, M.D., MBA, as an independent director to its Board of Directors, effective April 1, 2026, at which time he will also assume the role of Chair of the Board. Dr. Nader brings more than 30 years of leadership experience across the biotechnology and pharmaceutical industry and currently serves as an Independent Director of Moderna, Inc. (NASDAQ:MRNA), a glo

    2/23/26 4:01:00 PM ET
    $MRNA
    $TECX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Skyhawk Security Appoints Jason Schaaf as Chief Revenue Officer

    TEL AVIV, Israel, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Skyhawk Security, the leader in Purple Team-Powered Cloud Security, today announced the appointment of Jason Schaaf as Chief Revenue Officer. Schaaf will lead Skyhawk's global go-to-market organization—including sales, marketing, and channel partnerships—to accelerate the company's next phase of growth. Schaaf joins Skyhawk at a pivotal moment. The company recently launched its Agentic AI capabilities, enabling continuous security control validation across the entire cloud stack, a market-defining advancement that demands a go-to-market leader with the experience to scale rapidly. Schaaf brings a rare combination of impactful leadership

    2/18/26 9:00:00 AM ET
    $RDWR
    Real Estate

    $RDHL
    $RDWR
    $SILV
    $SNES
    Financials

    Live finance-specific insights

    View All

    Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results

    — Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years — — Conference call today at 4:30 p.m. ET — BRISBANE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today reported financial results for the fourth quarter and full-year of 2025. "2025 was a year of disciplined execution for Pacira. With the launch of our 5x30 strategy, we reignited momentum across the business and delivered strong, measurable progress. Our products benefitted more than 2.5 million patients

    2/26/26 4:01:00 PM ET
    $PCRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BioCryst Reports Full Year 2025 Financial Results and Provides Business Update

    —Full year 2025 ORLADEYO® net revenue of $601.8 million (+38% y-o-y; +43% y-o-y excluding European ORLADEYO revenue following the sale of the European ORLADEYO business to Neopharmed Gentili S.p.A. on October 1, 2025)— —Record GAAP and non-GAAP operating profit for full year 2025— —Maintained full year 2026 ORLADEYO revenue guidance between $625 and $645 million— —Received FDA approval for ORLADEYO oral pellets for patients with HAE Aged 2 to <12 Years— —Completed Acquisition of Astria Therapeutics— RESEARCH TRIANGLE PARK, N.C., Feb. 26, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today reported financial results for the full year ended December 31, 2025, an

    2/26/26 7:00:00 AM ET
    $BCRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update

    Full year 2025 net revenues of $655 million and fourth quarter net revenues of $174 million Optune Pax® approved by the U.S. FDA for the treatment of locally advanced pancreatic cancer, commercial launch underway Novocure (NASDAQ:NVCR) today reported financial results for the quarter and full year ended December 31, 2025. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, Tumor Treating Fields (TTFields). "In 2025, a record number of patients received treatment with Novocure's Tumor Treating Fields therapy, a milestone that reflects our growth and commitment to advanc

    2/26/26 7:00:00 AM ET
    $NVCR
    Medical/Dental Instruments
    Health Care

    $RDHL
    $RDWR
    $SILV
    $SNES
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/13/24 9:05:42 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/13/24 5:07:48 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    SEC Form SC 13G filed by PSQ Holdings Inc.

    SC 13G - PSQ Holdings, Inc. (0001847064) (Subject)

    12/12/24 11:50:43 AM ET
    $PSQH
    Advertising
    Consumer Discretionary